Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is 7Β 967,87Β β½, with a 24-hour trading volume of 124,98BΒ β½. The asset's market cap is 13,85TΒ β½, after moving 0.04% in the last day.
Tokenized Abbott Laboratories is trading at 8Β 079,19Β β½, with a tokenized market cap of 143,66MΒ β½ and a 24-hour trading volume of 369,33MΒ β½. The tokenized asset has moved 0.76% in the past 24 hours.